Sensex slips 250 points from intraday high as Nifty drops below 22,700

AI Market Summary
Indian equities faded from intraday highs as Nifty slipped below 22,700, pressured by heavy foreign investor selling and renewed inflation concerns from Brent rising above $103 after Iran-sanctions easing was denied. Pharma and healthcare underperformed, reinforcing a defensive tone. Technical resistance near 22,750 is cited as limiting risk appetite, keeping near-term sentiment cautious across Indian risk assets.
Impact level
● Medium
Affected assets
NCSINIFTY52USD/USDT-0.79%
AI Insight · NCSINIFTY52USD/USDTAI Insight
▼ Bearish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Indian equities reversed from intraday highs, with the Sensex sliding 250 points and the Nifty falling below 22,700. The move was pressured by record foreign selling, including a net Rs 99.8 billion outflow on Tuesday and $2.7 billion of withdrawals in September. Brent crude rising above $103 a barrel added to inflation concerns. Pharma and healthcare led the decline, with the Nifty Healthcare index down 1.7%, while sentiment also turned cautious on technical resistance.